<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-29420</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0082913</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Anesthesiology</subject><subj-group><subject>General anesthesia</subject><subject>Perioperative critical care</subject></subj-group></subj-group><subj-group><subject>Cardiovascular</subject></subj-group><subj-group><subject>Clinical research design</subject><subj-group><subject>Meta-analyses</subject><subject>Systematic reviews</subject></subj-group></subj-group><subj-group><subject>Critical care and emergency medicine</subject><subj-group><subject>Ventilatory support</subject></subj-group></subj-group><subj-group><subject>Drugs and devices</subject><subj-group><subject>Pharmacoepidemiology</subject></subj-group></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Pharmacoepidemiology</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Dexmedetomidine as a Sedative Agent in Critically Ill Patients: A Meta-Analysis of Randomized Controlled Trials</article-title>
<alt-title alt-title-type="running-head">Dexmedetomidine in Critically Ill Patients</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pasin</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Greco</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Feltracco</surname><given-names>Paolo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vittorio</surname><given-names>Annalisa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Neto</surname><given-names>Caetano Nigro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cabrini</surname><given-names>Luca</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Landoni</surname><given-names>Giovanni</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Finco</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zangrillo</surname><given-names>Alberto</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Anesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan, Italy</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Pharmacology and Anesthesiology, University Hospital of Padua, Padua, Italy</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Outcomes Research Consortium, Cleveland, Ohio, United States of America</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Medical Sciences “M. Aresu”, Cagliari University, Cagliari, Italy</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Mandell</surname><given-names>Mercedes Susan</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Colorado, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">landoni.giovanni@hsr.it</email></corresp>
<fn fn-type="conflict"><p>Giovanni Landoni is a PLOS ONE Editorial Board member. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: LP TG PF AV CNN LC GL GF AZ. Performed the experiments: LP TG PF AV CNN LC GL GF AZ. Analyzed the data: LP TG PF AV CNN LC GL GF AZ. Contributed reagents/materials/analysis tools: LP TG PF AV CNN LC GL GF AZ. Wrote the paper: LP TG PF AV CNN LC GL GF AZ.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>31</day><month>12</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>12</issue>
<elocation-id>e82913</elocation-id>
<history>
<date date-type="received"><day>16</day><month>7</month><year>2013</year></date>
<date date-type="accepted"><day>29</day><month>10</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Pasin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Introduction</title>
<p>The effect of dexmedetomidine on length of intensive care unit (ICU) stay and time to extubation is still unclear.</p>
</sec><sec>
<title>Materials and Methods</title>
<p>Pertinent studies were independently searched in BioMedCentral, PubMed, Embase, and the Cochrane Central Register of clinical trials (updated February first 2013). Randomized studies (dexmedetomidine versus any comparator) were included if including patients mechanically ventilated in an intensive care unit (ICU). Co-primary endpoints were the length of ICU stay (days) and time to extubation (hours). Secondary endpoint was mortality rate at the longest follow-up available.</p>
</sec><sec>
<title>Results</title>
<p>The 27 included manuscripts (28 trials) randomized 3,648 patients (1,870 to dexmedetomidine and 1,778 to control). Overall analysis showed that the use of dexmedetomidine was associated with a significant reduction in length of ICU stay (weighted mean difference (WMD) = −0.79 [−1.17 to −0.40] days, p for effect &lt;0.001) and of time to extubation (WMD = −2.74 [−3.80 to −1.65] hours, p for effect &lt;0.001). Mortality was not different between dexmedetomidine and controls (risk ratio = 1.00 [0.84 to 1.21], p for effect = 0.9). High heterogeneity between included studies was found.</p>
</sec><sec>
<title>Conclusions</title>
<p>This meta-analysis of randomized controlled studies suggests that dexmedetomidine could help to reduce ICU stay and time to extubation, in critically ill patients even if high heterogeneity between studies might confound the interpretation of these results.</p>
</sec></abstract>
<funding-group><funding-statement>The study was conducted exclusively with departmental sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="13"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Dexmedetomidine was approved by the Food and Drug Administration (FDA) at the end of 1999 as a short-term medication (&lt;24 hours) for analgesia and sedation in mechanical ventilated intensive care unit (ICU) patients. In 2008, the FDA approved a new indication in non intubated patients requiring sedation before and/or during surgical and non-surgical procedures. Dexmedetomidine is a highly selective a2-adrenergic receptor agonist, which binds to transmembrane G protein-binding adrenoreceptors in the periphery (α2A), brain and spinal cord (α2B, α2C) tissues <xref ref-type="bibr" rid="pone.0082913-Paris1">[1]</xref>. In contrast to other sedative agents, dexmedetomidine, by acting on a2 receptors in the locus caeruleus <xref ref-type="bibr" rid="pone.0082913-Huupponen1">[2]</xref>, has potential analgesic effects <xref ref-type="bibr" rid="pone.0082913-Guo1">[3]</xref> without respiratory depression <xref ref-type="bibr" rid="pone.0082913-Iirola1">[4]</xref>, <xref ref-type="bibr" rid="pone.0082913-Morsch1">[5]</xref>. Only one meta-analysis of randomized controlled trials (RCTs) <xref ref-type="bibr" rid="pone.0082913-Tan1">[6]</xref> was published so far: Tan and Ho reported a reduction in length of ICU stay, but not in duration of time to extubation when dexmedetomidine was compared with alternative sedative agents.</p>
<p>Since several RCTs <xref ref-type="bibr" rid="pone.0082913-AbdAziz1">[7]</xref>–<xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref>, including two large ones <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref>, were recently published, and one further RCT <xref ref-type="bibr" rid="pone.0082913-Sahin1">[15]</xref> was not included in the previous meta-analysis <xref ref-type="bibr" rid="pone.0082913-Tan1">[6]</xref> we decided to perform an updated meta-analysis of all the RCTs ever performed on dexmedetomidine versus any comparator in the ICU setting to evaluate time to extubation, ICU stay and survival.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Search Strategy</title>
<p>Pertinent studies were independently searched in BioMedCentral, PubMed, Embase, and the Cochrane Central Register of clinical trials (updated February 1<sup>st</sup> 2013) by four trained investigators. The full PubMed search strategy aimed to include any RCTs ever performed in humans with dexmedetomidine in any clinical setting and is presented in the supplemental material (<xref ref-type="supplementary-material" rid="pone.0082913.s011">Text S1</xref>). In addition, we employed backward snowballing (i.e., scanning of references of retrieved articles and pertinent reviews) and contacted international experts for further studies with no language restriction.</p>
</sec><sec id="s2b">
<title>Study Selection</title>
<p>References were first independently examined at a title/abstract level by four investigators, with divergences resolved by consensus, and then, if potentially pertinent, retrieved as complete articles. The following inclusion criteria were used for potentially relevant studies: random allocation to treatment (dexmedetomidine versus any comparator with no restrictions on dose or time of administration); studies involving patients who required mechanical ventilation in an ICU. The exclusion criteria were duplicate publications (in this case we referred to the first article published while retrieved data from the article with the longest follow-up available), non-adult patients and lack of data on all of the following: ICU stay, time to extubation and mortality. Two investigators independently assessed compliance to selection criteria and selected studies for the final analysis, with divergences resolved by consensus.</p>
</sec><sec id="s2c">
<title>Data Abstraction and Study</title>
<p>Baseline, procedural, and outcome data were independently abstracted by four trained investigators (<xref ref-type="table" rid="pone-0082913-t001">table 1</xref> and <xref ref-type="table" rid="pone-0082913-t002">table 2</xref>). If a trial reported multiple comparisons <xref ref-type="bibr" rid="pone.0082913-Maldonado1">[25]</xref>, <xref ref-type="bibr" rid="pone.0082913-Ruokonen1">[34]</xref>, the comparators were aggregated as a single control group. At least two separate attempts at contacting original authors were made in cases of missing data. The co-primary endpoints of the present review were the length of ICU stay (days) and time to extubation (hours from randomization to extubation).</p>
<table-wrap id="pone-0082913-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.t001</object-id><label>Table 1</label><caption>
<title>Description of the 28 trials included in the meta-analysis.</title>
</caption><alternatives><graphic id="pone-0082913-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">First author</td>
<td align="left" rowspan="1" colspan="1">Year</td>
<td align="left" rowspan="1" colspan="1">Setting</td>
<td align="left" rowspan="1" colspan="1">Dex patients</td>
<td align="left" rowspan="1" colspan="1">Control patients</td>
<td align="left" rowspan="1" colspan="1">Comparator</td>
<td align="left" rowspan="1" colspan="1">Comparator dose</td>
<td align="left" rowspan="1" colspan="1">Follow-up</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Aziz AN <xref ref-type="bibr" rid="pone.0082913-AbdAziz1">[7]</xref></td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">Morphine</td>
<td align="left" rowspan="1" colspan="1">4.6–46 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">24 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Corbett SM <xref ref-type="bibr" rid="pone.0082913-Corbett1">[21]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">46</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">0.2–0.7 µg/kg/h or 5–75 µg/kg/min</td>
<td align="left" rowspan="1" colspan="1">ICU stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Elbaradie S <xref ref-type="bibr" rid="pone.0082913-Elbaradie1">[22]</xref></td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">Major surgeries</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">Bolus dose of 1 mg/kg followed by an infusion of 0.5–1 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">24 hours after commencement of sedative infusions</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Esmaoglu A <xref ref-type="bibr" rid="pone.0082913-Esmaoglu1">[23]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Post caesarean eclampsia</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">Midazolam</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 0.05 mg/kg followed by an infusion of 0.1 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">ICU stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Herr DL <xref ref-type="bibr" rid="pone.0082913-Herr1">[24]</xref></td>
<td align="left" rowspan="1" colspan="1">2003</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">148</td>
<td align="left" rowspan="1" colspan="1">147</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">24 hours after discharge from ICU</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jakob SM MIDEX <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">249</td>
<td align="left" rowspan="1" colspan="1">251</td>
<td align="left" rowspan="1" colspan="1">Midazolam</td>
<td align="left" rowspan="1" colspan="1">0.03–0.2 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">45 days</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jakob SM PRODEX <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">251</td>
<td align="left" rowspan="1" colspan="1">247</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">0.3–4.0 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">45 days</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Khalil MA <xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">25</td>
<td align="left" rowspan="1" colspan="1">Placebo</td>
<td align="left" rowspan="1" colspan="1">Loading dose 1 µg/kg over 10 minutes followed by a maintenance infusion of 0.5 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Hospital stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Leino K <xref ref-type="bibr" rid="pone.0082913-Leino1">[9]</xref></td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">Placebo</td>
<td align="left" rowspan="1" colspan="1">39 ml/h for 20 min, 24.5 ml/h for 40 minutes, 14 ml/h for 60 min, 10.5 ml/h for 120 min and then 7 ml/h</td>
<td align="left" rowspan="1" colspan="1">48 hours after catheter insertion</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Maldonado JR <xref ref-type="bibr" rid="pone.0082913-Maldonado1">[25]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">4040</td>
<td align="left" rowspan="1" colspan="1">3840</td>
<td align="left" rowspan="1" colspan="1">Propofol, midazolam</td>
<td align="left" rowspan="1" colspan="1">Propofol: 25–50 µg/kg/min; Midazolam: 0.5–2 mg/h</td>
<td align="left" rowspan="1" colspan="1">Hospital stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Martin E <xref ref-type="bibr" rid="pone.0082913-Martin1">[26]</xref></td>
<td align="left" rowspan="1" colspan="1">2003</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">203</td>
<td align="left" rowspan="1" colspan="1">198</td>
<td align="left" rowspan="1" colspan="1">Placebo</td>
<td align="left" rowspan="1" colspan="1">1 µg/kg for 10 min (loading dose) and then 0.4 µg/kg/h. The latter rate could be adjusted within the range of 0.2 to 0.7 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">24 hours from infusion end</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Memis D <xref ref-type="bibr" rid="pone.0082913-Memis1">[27]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">12</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">2 mg/kg/h over 5-h infusion</td>
<td align="left" rowspan="1" colspan="1">ICU stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Memis D <xref ref-type="bibr" rid="pone.0082913-Memi1">[28]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">Midazolam</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 0.2 mg/kg over 10 min followed by 0.1–0.5 mg/kg/h infusion</td>
<td align="left" rowspan="1" colspan="1">ICU stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Memis D <xref ref-type="bibr" rid="pone.0082913-Memi2">[29]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">1 mg/kg over 15 min followed by a maintenance dose of 1 to 3 mg/kg per hour</td>
<td align="left" rowspan="1" colspan="1">ICU stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MendaF<xref ref-type="bibr" rid="pone.0082913-Menda1">[10]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">Placebo</td>
<td align="left" rowspan="1" colspan="1">1 µg/kg in 15 min</td>
<td align="left" rowspan="1" colspan="1">ICU stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ozkan N <xref ref-type="bibr" rid="pone.0082913-Ozkan1">[30]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">Midazolam</td>
<td align="left" rowspan="1" colspan="1">0.05–0.07 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">24 hours post extubation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pandharipande PP <xref ref-type="bibr" rid="pone.0082913-Pandharipande1">[31]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">52</td>
<td align="left" rowspan="1" colspan="1">51</td>
<td align="left" rowspan="1" colspan="1">Lorazepam</td>
<td align="left" rowspan="1" colspan="1">Maximum 10 mg/hr</td>
<td align="left" rowspan="1" colspan="1">12 months</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Reade MC <xref ref-type="bibr" rid="pone.0082913-Reade1">[32]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">Haloperidol</td>
<td align="left" rowspan="1" colspan="1">0.5–2 mg/hour preceded by a loading dose of 2.5 mg if desired</td>
<td align="left" rowspan="1" colspan="1">Hospital stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Riker RR <xref ref-type="bibr" rid="pone.0082913-Riker1">[33]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">244</td>
<td align="left" rowspan="1" colspan="1">122</td>
<td align="left" rowspan="1" colspan="1">Midazolam</td>
<td align="left" rowspan="1" colspan="1">Loading dose 0.05 mg/kg then infusion rate 0.02–0.1 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">30 days</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ruokonen E <xref ref-type="bibr" rid="pone.0082913-Ruokonen1">[34]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">41</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">Propofol Midazolam</td>
<td align="left" rowspan="1" colspan="1">Propofol: 2.4 mg/kg/h for 1 h and then adjusted stepwise at 0.8, 1.6, 2.4, 3.2, and 4.0 mg/kg/h; Midazolam: boluses (1–2 mg), starting at 3 boluses per hour for 1 h, and thereafter 1–4 boluses per h, and if not sufficient as continuous infusion</td>
<td align="left" rowspan="1" colspan="1">45 days</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sahin N <xref ref-type="bibr" rid="pone.0082913-Sahin1">[15]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">Midazolam</td>
<td align="left" rowspan="1" colspan="1">0.1 mg/kg/h intraoperative; 0.5–1 µg/kg/min ICU</td>
<td align="left" rowspan="1" colspan="1">12 hours postoperatory</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shehabi Y <xref ref-type="bibr" rid="pone.0082913-Shehabi1">[35]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">154</td>
<td align="left" rowspan="1" colspan="1">152</td>
<td align="left" rowspan="1" colspan="1">Morphine</td>
<td align="left" rowspan="1" colspan="1">10–70 µg/kg/ml</td>
<td align="left" rowspan="1" colspan="1">Hospital stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tasdogan M <xref ref-type="bibr" rid="pone.0082913-Tasdogan1">[36]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Abdominal surgery</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">1 mg/kg over 15 minutes followed by a maintenance dose of 1–3 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">25 days</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Terao Y <xref ref-type="bibr" rid="pone.0082913-Terao1">[11]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Cervical spine surgery</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">0.1 mg/kg/min for 10 minutes as a loading dose, followed by a continuous infusion at 1 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Hospital stay</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Triltsch AE <xref ref-type="bibr" rid="pone.0082913-Triltsch1">[37]</xref></td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">Placebo</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 6 µg/kg/h 1 for 10 min; maintenance infusion of 0.1–0.7 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">24 hours after the end of study drug infusion</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Venn RM <xref ref-type="bibr" rid="pone.0082913-Venn1">[38]</xref></td>
<td align="left" rowspan="1" colspan="1">2001</td>
<td align="left" rowspan="1" colspan="1">Major surgery</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">Propofol</td>
<td align="left" rowspan="1" colspan="1">1–3 mg/kg/h after loading dose of up to 1 mg/kg over 10 min</td>
<td align="left" rowspan="1" colspan="1">35 days</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wan LJ <xref ref-type="bibr" rid="pone.0082913-Wan1">[12]</xref></td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">102</td>
<td align="left" rowspan="1" colspan="1">98</td>
<td align="left" rowspan="1" colspan="1">Midazolam</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">24 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yao L <xref ref-type="bibr" rid="pone.0082913-Yao1">[13]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">35</td>
<td align="left" rowspan="1" colspan="1">38</td>
<td align="left" rowspan="1" colspan="1">Midazolam</td>
<td align="left" rowspan="1" colspan="1">Loading dose (0.06 mg/kg) and then maintained with 0.04–0.20 mg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Time on mechanical ventilation</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>Dex: dexmedetomidine; ICU: Intensive Care Unit; NA: not available; RASS: Richmond Agitation Sedation Scale; BIS: BispectralIndex ; MAAS: Motor Activity Assessment Scale.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0082913-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.t002</object-id><label>Table 2</label><caption>
<title>Doses, sedation scales and target sedation levels.</title>
</caption><alternatives><graphic id="pone-0082913-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">First author</td>
<td align="left" rowspan="1" colspan="1">Study endpoint</td>
<td align="left" rowspan="1" colspan="1">Dexmedetomidine dose</td>
<td align="left" rowspan="1" colspan="1">Start study drug</td>
<td align="left" rowspan="1" colspan="1">Stop study drug</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Aziz NA <xref ref-type="bibr" rid="pone.0082913-AbdAziz1">[7]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">0.03–0.25 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">ICU arrival</td>
<td align="left" rowspan="1" colspan="1">After 24 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Corbett SM <xref ref-type="bibr" rid="pone.0082913-Begg1">[17]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in 15 min, followed by a 0.4/µg/kg/h infusion</td>
<td align="left" rowspan="1" colspan="1">During surgery, after CPB</td>
<td align="left" rowspan="1" colspan="1">Propofol was discontinued before extubation while dexmedetomidine was continued for up to 1 hour after extubation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Elbaradie S <xref ref-type="bibr" rid="pone.0082913-Elbaradie1">[22]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 2.5 µg/kgin10 min followed by a 0.2–0.5 µg/kg/h infusion</td>
<td align="left" rowspan="1" colspan="1">ICU arrival</td>
<td align="left" rowspan="1" colspan="1">Before extubation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Esmaoglu A <xref ref-type="bibr" rid="pone.0082913-Esmaoglu1">[23]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in 20 min followed by a0.7 µg/kg/h infusion</td>
<td align="left" rowspan="1" colspan="1">ICU arrival</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Herr DL <xref ref-type="bibr" rid="pone.0082913-Herr1">[24]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in20 min followed by a0.4 µg/kg/h infusion. After transfer to the ICU, the infusion rate was titrated in the range of 0.2 to 0.7 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Sternal closure</td>
<td align="left" rowspan="1" colspan="1">6–24 hours after extubation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jakob SM MIDEX <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">0.2–1.4 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Within 72 hours after ICU admission</td>
<td align="left" rowspan="1" colspan="1">Extubation, 14 days maximum</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jakob SM PRODEX <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">0.2–1.4 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Within 72 hours after ICU admission</td>
<td align="left" rowspan="1" colspan="1">Extubation, 14 days maximum</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Khalil MA <xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in 10 minutes followed by a 0.5 µg/kg/h infusion</td>
<td align="left" rowspan="1" colspan="1">After induction of general anaesthesia</td>
<td align="left" rowspan="1" colspan="1">After stabilization of haemodynamics in the ICU</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Leino K <xref ref-type="bibr" rid="pone.0082913-Leino1">[9]</xref></td>
<td align="left" rowspan="1" colspan="1">Renal effects</td>
<td align="left" rowspan="1" colspan="1">Five-step infusion of 4 µg/ml with the following decreasing infusion rate: 39 ml/h for 20 min, 24.5 ml/h for 40 min, 14 ml/h for 60 min, 10.5 ml/h for 120 min and then 7 ml/h (rates needed to achieve a pseudo steady-state plasma concentration of 0.60 µg/ml)</td>
<td align="left" rowspan="1" colspan="1">Immediately after anaesthesia induction</td>
<td align="left" rowspan="1" colspan="1">4 h after ICU arrival</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Maldonado JR <xref ref-type="bibr" rid="pone.0082913-Maldonado1">[25]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 0,4 µg/kg followed by 0.2–0.7 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">After CPB weaning</td>
<td align="left" rowspan="1" colspan="1">Maximum 24 h</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Martin E <xref ref-type="bibr" rid="pone.0082913-Martin1">[26]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in 10 min followed by 0.4 µg/kg/h. The latter rate could be adjusted within the range of 0.2 to 0.7 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Within 1 hour after ICU admission</td>
<td align="left" rowspan="1" colspan="1">For a minimum of 6 hours post extubation; total time was &lt;24 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Memis D <xref ref-type="bibr" rid="pone.0082913-Memis1">[27]</xref></td>
<td align="left" rowspan="1" colspan="1">Gastric emptying</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 2.5 µg/kg in 10 min followed by 0.2 µg kg/h over 5 h infusion</td>
<td align="left" rowspan="1" colspan="1">Within 4 hours after ICU admission</td>
<td align="left" rowspan="1" colspan="1">5 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Memis D <xref ref-type="bibr" rid="pone.0082913-Memi1">[28]</xref></td>
<td align="left" rowspan="1" colspan="1">Inflammatory responses and gastric intramucosal pH</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in 10 min followed by 0.2–2.5 µg/kg over 24 h infusion</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Memis D <xref ref-type="bibr" rid="pone.0082913-Memi2">[29]</xref></td>
<td align="left" rowspan="1" colspan="1">Indocyanine green elimination</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in 10 min followed by a maintenance of 0.2–2.5 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">24 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Menda F <xref ref-type="bibr" rid="pone.0082913-Menda1">[10]</xref></td>
<td align="left" rowspan="1" colspan="1">Haemodynamic response to endotracheal intubation</td>
<td align="left" rowspan="1" colspan="1">1 µg/kg in 15 min</td>
<td align="left" rowspan="1" colspan="1">Anaesthesia induction</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ozkan N <xref ref-type="bibr" rid="pone.0082913-Ozkan1">[30]</xref></td>
<td align="left" rowspan="1" colspan="1">Haemodynamics and mixed venous oxygen saturation</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg followed by 0.2–0.4 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Anaesthesia induction</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pandharipande PP <xref ref-type="bibr" rid="pone.0082913-Pandharipande1">[31]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Maximum 1.5 µg/kg/hr</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">Until extubation, for maximum 120 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Reade MC <xref ref-type="bibr" rid="pone.0082913-Reade1">[32]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1.0 µg/kg in 20 min (if desired) followed by 0.2–0.7 µg/kg/hour</td>
<td align="left" rowspan="1" colspan="1">ICU</td>
<td align="left" rowspan="1" colspan="1">As long as clinically indicated, including following extubation if required</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Riker RR <xref ref-type="bibr" rid="pone.0082913-Riker1">[33]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg followed by 0.2–1.4 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Within 96 hours after intubation</td>
<td align="left" rowspan="1" colspan="1">Extubation, 30 days maximum</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ruokonen E <xref ref-type="bibr" rid="pone.0082913-Ruokonen1">[34]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">0.8 µg/kg/h for 1 h and then adjusted stepwise at 0.25, 0.5, 0.8, 1.1, and 1.4 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Within 72 hours after ICU admission</td>
<td align="left" rowspan="1" colspan="1">Maximum 14 days</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sahin N <xref ref-type="bibr" rid="pone.0082913-Sahin1">[15]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality and haemodynamics</td>
<td align="left" rowspan="1" colspan="1">0.4 µg/kg/h intraoperative; 0.2–0.4 µg/kg/h in ICU</td>
<td align="left" rowspan="1" colspan="1">Anesthesia induction</td>
<td align="left" rowspan="1" colspan="1">45 hours after extubation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shehabi Y <xref ref-type="bibr" rid="pone.0082913-Shehabi1">[35]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">0.1–0.7 µg/kg/ml</td>
<td align="left" rowspan="1" colspan="1">Within 1 hour after ICU admission</td>
<td align="left" rowspan="1" colspan="1">Removal of chest drains, maximum 48 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tasdogan M <xref ref-type="bibr" rid="pone.0082913-Tasdogan1">[36]</xref></td>
<td align="left" rowspan="1" colspan="1">Inflammatory responses and intra abdominal pressure</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in 10 min followed by 0.2–2.5 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">ICU arrival</td>
<td align="left" rowspan="1" colspan="1">24 hours</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Terao Y <xref ref-type="bibr" rid="pone.0082913-Terao1">[11]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 0.1 µg/kg/min in 10 minutes followed by 0.4 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">ICU arrival</td>
<td align="left" rowspan="1" colspan="1">First postoperative morning</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Triltsch AE <xref ref-type="bibr" rid="pone.0082913-Triltsch1">[37]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 6 µg/kg/h in 10 min followed by 0.1–0.7 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">Within 1 hour after ICU admission</td>
<td align="left" rowspan="1" colspan="1">6–7 hours after extubation, maximum overall 72 h</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Venn RM <xref ref-type="bibr" rid="pone.0082913-Venn1">[38]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 2,5 µg/kg/h followed by 0,2–2,5 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">ICU arrival</td>
<td align="left" rowspan="1" colspan="1">Extubation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wan LJ <xref ref-type="bibr" rid="pone.0082913-Wan1">[12]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yao L <xref ref-type="bibr" rid="pone.0082913-Yao1">[13]</xref></td>
<td align="left" rowspan="1" colspan="1">Sedation quality</td>
<td align="left" rowspan="1" colspan="1">Loading dose of 1 µg/kg in 10 min followed by 0.2–0.7 µg/kg/h</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p>ICU: Intensive Care Unit; CPB: cardiopulmonary bypass; NA: not available.</p></fn></table-wrap-foot></table-wrap>
<p>The secondary endpoint was mortality rate at the longest follow-up available. Adverse effects (hypotension and bradycardia as per author definition) were also analysed. Further endpoints included the number of patients requiring rescue doses of analgesic (opioids) or sedative (propofol, benzodiazepines, or any antipsychotics) drugs and the number of patients completely comfortable during ICU stay.</p>
<p>The internal validity and risk of bias of included trials was appraised by two independent reviewers according to the latest version of the “Risk of bias assessment tool” developed by The Cochrane collaboration <xref ref-type="bibr" rid="pone.0082913-Higgins1">[16]</xref>, with divergences resolved by consensus. Publication bias was assessed by visually inspecting funnel plots and scatter plots and by analytical appraisal based on the Egger's linear regression test and on the Peters' test for asymmetry. According to the Egger <xref ref-type="bibr" rid="pone.0082913-Begg1">[17]</xref> or Peters <xref ref-type="bibr" rid="pone.0082913-Peters1">[18]</xref> methods for publication bias evaluation, a two-sided p value of 0.10 or less was regarded as significant.</p>
</sec><sec id="s2d">
<title>Data Analysis and Synthesis</title>
<p>Computations were performed with Stata release 11, College Station, TX) and SAS 2002–08 program (release 9.2, SAS Institute, Inc, Cary, NC). Hypothesis of statistical heterogeneity was tested by means of Cochran Q test, with statistical significance set at the two-tailed 0.10 level, whereas extent of statistical consistency was measured with I<sup>2</sup>, defined as 100%×(Q-df)/Q, where Q is Cochran's heterogeneity statistic and df the degrees of freedom. Binary outcomes from individual studies were analysed to compute individual and pooled risk ratio (RR) with pertinent 95% confidence interval (CI), by means of inverse variance method and with a fixed-effect model in case of low statistical inconsistency (I<sup>2</sup>&lt;25%) or with random-effect model (which better accommodates clinical and statistical variations) in case of moderate or high statistical inconsistency (I<sup>2</sup>&gt;25%). Standardized mean differences (SMD), or weighted mean difference (WMD), and 95% confidence intervals were computed for continuous variables using the same models as just described. To evaluate if the small study effect had an influence on the treatment effect estimate, in case of evidence of between-study heterogeneity (I<sup>2</sup>&gt;25), we compared the results of both fixed and random effect models. Sensitivity analyses were performed by sequentially removing each study and reanalysing the remaining dataset (producing a new analysis for each study removed) and by analysing only data from blinded studies and studies with low risk of bias.</p>
<p>Statistical significance was set at the two-tailed 0.05 level for hypothesis testing. Unadjusted p values are reported throughout. This study was performed in compliance with The Cochrane Collaboration and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines <xref ref-type="bibr" rid="pone.0082913-Higgins1">[16]</xref>, <xref ref-type="bibr" rid="pone.0082913-BiondiZoccai1">[19]</xref>, <xref ref-type="bibr" rid="pone.0082913-Liberati1">[20]</xref> (<xref ref-type="supplementary-material" rid="pone.0082913.s001">Checklist S1</xref>).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Study Characteristics</title>
<p>Database searches, snowballing, and contacts with experts yielded a total of 573 articles. The flow chart to select the final 27 manuscripts (28 trials) <xref ref-type="bibr" rid="pone.0082913-AbdAziz1">[7]</xref>–<xref ref-type="bibr" rid="pone.0082913-Sahin1">[15]</xref>, <xref ref-type="bibr" rid="pone.0082913-Corbett1">[21]</xref>–<xref ref-type="bibr" rid="pone.0082913-Venn1">[38]</xref> is detailed in <xref ref-type="fig" rid="pone-0082913-g001">figure 1</xref>, with major exclusions available in the supplemental material (<xref ref-type="supplementary-material" rid="pone.0082913.s012">Texts S2</xref> and <xref ref-type="supplementary-material" rid="pone.0082913.s013">S3</xref>).</p>
<fig id="pone-0082913-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.g001</object-id><label>Figure 1</label><caption>
<title>Flow diagram.</title>
<p>The flow chart to select the final 27 manuscripts (28 trials).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.g001" position="float" xlink:type="simple"/></fig>
<p>The 27 included manuscripts randomized 3,648 patients (1,870 to dexmedetomidine and 1,778 to control) (<xref ref-type="table" rid="pone-0082913-t001">tables 1</xref> and <xref ref-type="table" rid="pone-0082913-t002">2</xref>). Clinical heterogeneity was mostly due to setting, control treatment, and follow-up duration. Indeed, 13 trials used dexmedetomidine in a general ICU setting <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref>, <xref ref-type="bibr" rid="pone.0082913-Wan1">[12]</xref>, <xref ref-type="bibr" rid="pone.0082913-Yao1">[13]</xref>, <xref ref-type="bibr" rid="pone.0082913-Martin1">[26]</xref>–<xref ref-type="bibr" rid="pone.0082913-Memi2">[29]</xref>, <xref ref-type="bibr" rid="pone.0082913-Pandharipande1">[31]</xref>–<xref ref-type="bibr" rid="pone.0082913-Ruokonen1">[34]</xref>, <xref ref-type="bibr" rid="pone.0082913-Triltsch1">[37]</xref>, ten in cardiac surgery ICU patients <xref ref-type="bibr" rid="pone.0082913-AbdAziz1">[7]</xref>, <xref ref-type="bibr" rid="pone.0082913-Leino1">[9]</xref>, <xref ref-type="bibr" rid="pone.0082913-Menda1">[10]</xref>, <xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref>, <xref ref-type="bibr" rid="pone.0082913-Sahin1">[15]</xref>, <xref ref-type="bibr" rid="pone.0082913-Corbett1">[21]</xref>, <xref ref-type="bibr" rid="pone.0082913-Herr1">[24]</xref>, <xref ref-type="bibr" rid="pone.0082913-Maldonado1">[25]</xref>, <xref ref-type="bibr" rid="pone.0082913-Ozkan1">[30]</xref>, <xref ref-type="bibr" rid="pone.0082913-Shehabi1">[35]</xref>, four in major non-cardiac surgery ICU patients <xref ref-type="bibr" rid="pone.0082913-Terao1">[11]</xref>, <xref ref-type="bibr" rid="pone.0082913-Elbaradie1">[22]</xref>, <xref ref-type="bibr" rid="pone.0082913-Tasdogan1">[36]</xref>, <xref ref-type="bibr" rid="pone.0082913-Venn1">[38]</xref> and one after caesarean section-eclampsia admitted to ICU <xref ref-type="bibr" rid="pone.0082913-Esmaoglu1">[23]</xref>. Different techniques of dexmedetomidine administration were used: in 18 trials the continuous infusion was preceded by a loading dose that was often 1 mcg/kg <xref ref-type="bibr" rid="pone.0082913-Yao1">[13]</xref>, <xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref>, <xref ref-type="bibr" rid="pone.0082913-Begg1">[17]</xref>, <xref ref-type="bibr" rid="pone.0082913-Esmaoglu1">[23]</xref>, <xref ref-type="bibr" rid="pone.0082913-Herr1">[24]</xref>, <xref ref-type="bibr" rid="pone.0082913-Martin1">[26]</xref>, <xref ref-type="bibr" rid="pone.0082913-Memi1">[28]</xref>–<xref ref-type="bibr" rid="pone.0082913-Ozkan1">[30]</xref>, <xref ref-type="bibr" rid="pone.0082913-Reade1">[32]</xref>, <xref ref-type="bibr" rid="pone.0082913-Riker1">[33]</xref>, <xref ref-type="bibr" rid="pone.0082913-Tasdogan1">[36]</xref> but that varied between 0.1 to 6 mcg/kg in other trials <xref ref-type="bibr" rid="pone.0082913-Terao1">[11]</xref>, <xref ref-type="bibr" rid="pone.0082913-Elbaradie1">[22]</xref>, <xref ref-type="bibr" rid="pone.0082913-Maldonado1">[25]</xref>, <xref ref-type="bibr" rid="pone.0082913-Memis1">[27]</xref>, <xref ref-type="bibr" rid="pone.0082913-Ozkan1">[30]</xref>, <xref ref-type="bibr" rid="pone.0082913-Ruokonen1">[34]</xref>, <xref ref-type="bibr" rid="pone.0082913-Triltsch1">[37]</xref>, <xref ref-type="bibr" rid="pone.0082913-Venn1">[38]</xref>. In other 6 trials only continuous infusion was used and ranged between 0.1 to 2.5 mcg/kg/h <xref ref-type="bibr" rid="pone.0082913-AbdAziz1">[7]</xref>–<xref ref-type="bibr" rid="pone.0082913-Leino1">[9]</xref>, <xref ref-type="bibr" rid="pone.0082913-Sahin1">[15]</xref>, <xref ref-type="bibr" rid="pone.0082913-Pandharipande1">[31]</xref>, <xref ref-type="bibr" rid="pone.0082913-Shehabi1">[35]</xref> while in one trial only the loading dose was used <xref ref-type="bibr" rid="pone.0082913-Menda1">[10]</xref> and one trial gave no details <xref ref-type="bibr" rid="pone.0082913-Wan1">[12]</xref>. Study quality appraisal indicated that trials were of medium quality (<xref ref-type="supplementary-material" rid="pone.0082913.s006">Table S1</xref>); in particular 12of them had a low risk of bias.</p>
<p>Six different comparators were identified: propofol in 11 study arms <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref>, <xref ref-type="bibr" rid="pone.0082913-Terao1">[11]</xref>, <xref ref-type="bibr" rid="pone.0082913-Begg1">[17]</xref>, <xref ref-type="bibr" rid="pone.0082913-Elbaradie1">[22]</xref>, <xref ref-type="bibr" rid="pone.0082913-Herr1">[24]</xref>, <xref ref-type="bibr" rid="pone.0082913-Maldonado1">[25]</xref>, <xref ref-type="bibr" rid="pone.0082913-Memis1">[27]</xref>, <xref ref-type="bibr" rid="pone.0082913-Memi2">[29]</xref>, <xref ref-type="bibr" rid="pone.0082913-Ruokonen1">[34]</xref>, <xref ref-type="bibr" rid="pone.0082913-Tasdogan1">[36]</xref>, <xref ref-type="bibr" rid="pone.0082913-Venn1">[38]</xref>, midazolam in 10 arms <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref>, <xref ref-type="bibr" rid="pone.0082913-Wan1">[12]</xref>, <xref ref-type="bibr" rid="pone.0082913-Yao1">[13]</xref>, <xref ref-type="bibr" rid="pone.0082913-Sahin1">[15]</xref>, <xref ref-type="bibr" rid="pone.0082913-Esmaoglu1">[23]</xref>, <xref ref-type="bibr" rid="pone.0082913-Maldonado1">[25]</xref>, <xref ref-type="bibr" rid="pone.0082913-Memi1">[28]</xref>, <xref ref-type="bibr" rid="pone.0082913-Ozkan1">[30]</xref>, <xref ref-type="bibr" rid="pone.0082913-Riker1">[33]</xref>, <xref ref-type="bibr" rid="pone.0082913-Ruokonen1">[34]</xref>, placebo in 5 arms <xref ref-type="bibr" rid="pone.0082913-Leino1">[9]</xref>, <xref ref-type="bibr" rid="pone.0082913-Menda1">[10]</xref>, <xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref>, <xref ref-type="bibr" rid="pone.0082913-Martin1">[26]</xref>, <xref ref-type="bibr" rid="pone.0082913-Triltsch1">[37]</xref>, morphine in 2 arms <xref ref-type="bibr" rid="pone.0082913-AbdAziz1">[7]</xref>, <xref ref-type="bibr" rid="pone.0082913-Shehabi1">[35]</xref>, haloperidol <xref ref-type="bibr" rid="pone.0082913-Reade1">[32]</xref> and lorazepam <xref ref-type="bibr" rid="pone.0082913-Pandharipande1">[31]</xref> in one study.</p>
</sec><sec id="s3b">
<title>Quantitative Data Synthesis</title>
<sec id="s3b1">
<title>Effect of dexmedetomidine on ICU stay and time to extubation</title>
<p>Overall analysis (<xref ref-type="fig" rid="pone-0082913-g002">figure 2</xref>; <xref ref-type="supplementary-material" rid="pone.0082913.s002">figure S1</xref>) showed that the use of dexmedetomidine was associated with a significant reduction in length of ICU stay (WMD = −0.79 [−1.17 to −0.40] days, p for effect &lt;0.001, p for heterogeneity&lt;0.001,I<sup>2</sup> = 93%, SMD = −0.48 [−0.78 to −0.18], p for effect  = 0.002, p for heterogeneity &lt;0.001, I<sup>2</sup> = 91%; with 17 studies and 2,424 patients included) with results confirmed when subanalyses were performed on studies including patients undergoing elective surgery (SMD = −0.60 [−1.05 to −0.15], p for effect = 0.008 with 8 studies included), in those including patients undergoing short term sedation (SMD = −0.45 [−0.81 to −0.09], p for effect = 0.02 with 11 studies included), in those including patients receiving a loading dose (SMD = −0.58 [−1.03 to −0.13], p for effect = 0.01 with 11 studies included) and in those receiving low (&lt;0.7 µg kg−1 h−1) maintenance dose of dexmedetomidine (SMD = −0.62 [−1.04 to −0.20], p for effect = 0.004 with 10 studies included) as detailed in <xref ref-type="table" rid="pone-0082913-t003">table 3</xref>.</p>
<fig id="pone-0082913-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.g002</object-id><label>Figure 2</label><caption>
<title>Forest plot for the length of ICU stay.</title>
<p>Overall analysis showed that the use of dexmedetomidine was associated with a significant reduction in length of ICU stay (SMD = −0.48 [−0.78 to −0.18] , p for effect = 0.002, p for heterogeneity &lt;0.001, I2 = 91% with 17 studies and 2,424 patients included). ICU = intensive care unit; CI = confidence interval; SMD = standardized mean difference; N = number; SD = standard deviation; Dex = dexmedetomidine.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.g002" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0082913-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.t003</object-id><label>Table 3</label><caption>
<title>Sensitivity analyses of intensive care unit stay and time to extubation.</title>
</caption><alternatives><graphic id="pone-0082913-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Outcome</td>
<td align="left" rowspan="1" colspan="1">Number of included trials</td>
<td align="left" rowspan="1" colspan="1">Dex patients</td>
<td align="left" rowspan="1" colspan="1">Controlpatients</td>
<td align="left" rowspan="1" colspan="1">SMD</td>
<td align="left" rowspan="1" colspan="1">95% CI</td>
<td align="left" rowspan="1" colspan="1">P for effect</td>
<td align="left" rowspan="1" colspan="1">P for heterogeneity</td>
<td align="left" rowspan="1" colspan="1">I<sup>2</sup> (%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Overall trials</td>
<td align="left" rowspan="1" colspan="1">28 trials (27 manuscripts)</td>
<td align="left" rowspan="1" colspan="1">1,870</td>
<td align="left" rowspan="1" colspan="1">1,778</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>ICU stay</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>17</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>1,274</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>1,150</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>−0.48</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>−0.78 to −0.18</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.002</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>&lt;0.001</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>91</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-Postoperative elective surgery patients</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">373</td>
<td align="left" rowspan="1" colspan="1">372</td>
<td align="left" rowspan="1" colspan="1">−0.60</td>
<td align="left" rowspan="1" colspan="1">−1.05 to −0.15</td>
<td align="left" rowspan="1" colspan="1">0.008</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">86</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">---- Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">337</td>
<td align="left" rowspan="1" colspan="1">336</td>
<td align="left" rowspan="1" colspan="1">−0.57</td>
<td align="left" rowspan="1" colspan="1">−1.11 to −0.03</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">89</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">---- CABG surgery</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">103</td>
<td align="left" rowspan="1" colspan="1">106</td>
<td align="left" rowspan="1" colspan="1">−0.76</td>
<td align="left" rowspan="1" colspan="1">−1.94 to 0.42</td>
<td align="left" rowspan="1" colspan="1">0.2</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">93</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">---- Non Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">−0.75</td>
<td align="left" rowspan="1" colspan="1">−1.23 to −0.27</td>
<td align="left" rowspan="1" colspan="1">0.002</td>
<td align="left" rowspan="1" colspan="1">0.3</td>
<td align="left" rowspan="1" colspan="1">23</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-ICU patients (non elective postoperative)</td>
<td align="left" rowspan="1" colspan="1">9</td>
<td align="left" rowspan="1" colspan="1">901</td>
<td align="left" rowspan="1" colspan="1">778</td>
<td align="left" rowspan="1" colspan="1">−0.38</td>
<td align="left" rowspan="1" colspan="1">−0.82 to 0.06</td>
<td align="left" rowspan="1" colspan="1">0.09</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">93</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-excluding outlier studies <xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref>, <xref ref-type="bibr" rid="pone.0082913-Reade1">[32]</xref>, <xref ref-type="bibr" rid="pone.0082913-Riker1">[33]</xref></td>
<td align="left" rowspan="1" colspan="1">13</td>
<td align="left" rowspan="1" colspan="1">1438</td>
<td align="left" rowspan="1" colspan="1">1427</td>
<td align="left" rowspan="1" colspan="1">−0.17</td>
<td align="left" rowspan="1" colspan="1">−0.29 to −0.05</td>
<td align="left" rowspan="1" colspan="1">0.005</td>
<td align="left" rowspan="1" colspan="1">0.15</td>
<td align="left" rowspan="1" colspan="1">28</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Long term sedation</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">849</td>
<td align="left" rowspan="1" colspan="1">726</td>
<td align="left" rowspan="1" colspan="1">−0.54</td>
<td align="left" rowspan="1" colspan="1">−1.09 to 0.008</td>
<td align="left" rowspan="1" colspan="1">0.053</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">95</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Short term sedation</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">425</td>
<td align="left" rowspan="1" colspan="1">424</td>
<td align="left" rowspan="1" colspan="1">−0.45</td>
<td align="left" rowspan="1" colspan="1">−0.81 to −0.09</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">82</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Daily interruption sedation</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">839</td>
<td align="left" rowspan="1" colspan="1">716</td>
<td align="left" rowspan="1" colspan="1">−0.38</td>
<td align="left" rowspan="1" colspan="1">−0.96 to 0.18</td>
<td align="left" rowspan="1" colspan="1">0.18</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">96</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- High maintenance dose</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">879</td>
<td align="left" rowspan="1" colspan="1">756</td>
<td align="left" rowspan="1" colspan="1">−0.31</td>
<td align="left" rowspan="1" colspan="1">−0.79 to 0.17</td>
<td align="left" rowspan="1" colspan="1">0.2</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">95</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Low maintenance dose(&lt;0.7 µg kg−1 h−1)</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">395</td>
<td align="left" rowspan="1" colspan="1">394</td>
<td align="left" rowspan="1" colspan="1">−0.62</td>
<td align="left" rowspan="1" colspan="1">−1.04 to −0.20</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">85</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Loading dose</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">281</td>
<td align="left" rowspan="1" colspan="1">282</td>
<td align="left" rowspan="1" colspan="1">−0.58</td>
<td align="left" rowspan="1" colspan="1">−1.03 to −0.13</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">83</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- No loading dose</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">993</td>
<td align="left" rowspan="1" colspan="1">868</td>
<td align="left" rowspan="1" colspan="1">−0.36</td>
<td align="left" rowspan="1" colspan="1">−0.81 to 0.10</td>
<td align="left" rowspan="1" colspan="1">0.13</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">96</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Loading dose and high maintenance dose</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">140</td>
<td align="left" rowspan="1" colspan="1">40</td>
<td align="left" rowspan="1" colspan="1">−0.09</td>
<td align="left" rowspan="1" colspan="1">−0.79 to 0.61</td>
<td align="left" rowspan="1" colspan="1">0.8</td>
<td align="left" rowspan="1" colspan="1">0.12</td>
<td align="left" rowspan="1" colspan="1">60</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- SENSITIVITY (including only blinded studies)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">891</td>
<td align="left" rowspan="1" colspan="1">768</td>
<td align="left" rowspan="1" colspan="1">−0.56</td>
<td align="left" rowspan="1" colspan="1">−1.09 to −0.04</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">95</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SENSITIVITY (including only low risk of bias studies)</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">1065</td>
<td align="left" rowspan="1" colspan="1">940</td>
<td align="left" rowspan="1" colspan="1">−0.44</td>
<td align="left" rowspan="1" colspan="1">−0.86 to −0.02</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">94</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SENSITIVITY (removing 1 study at time)</td>
<td colspan="8" align="left" rowspan="1">All 95% CIs of SDM&lt;0 and p&lt;0.05</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SMALL STUDY EFFECT (fixed model)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">−0.34</td>
<td align="left" rowspan="1" colspan="1">−0.43 to −0.26</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Time to extubation</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>24</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>1,804</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>1,674</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>−0.39</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>−0.66 to −0.11</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>0.005</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>&lt;0.001</bold></td>
<td align="left" rowspan="1" colspan="1"><bold>93</bold></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-Postoperative elective surgery patients</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">954</td>
<td align="left" rowspan="1" colspan="1">942</td>
<td align="left" rowspan="1" colspan="1">−0.31</td>
<td align="left" rowspan="1" colspan="1">−0.52 to −0.09</td>
<td align="left" rowspan="1" colspan="1">0.005</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">77</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">---- Cardiac surgery</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">558</td>
<td align="left" rowspan="1" colspan="1">555</td>
<td align="left" rowspan="1" colspan="1">−0.42</td>
<td align="left" rowspan="1" colspan="1">−0.75 to −0.10</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">83</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">---- CABG surgery</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">310</td>
<td align="left" rowspan="1" colspan="1">311</td>
<td align="left" rowspan="1" colspan="1">−0.59</td>
<td align="left" rowspan="1" colspan="1">−1.13 to −0.05</td>
<td align="left" rowspan="1" colspan="1">0.03</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">89</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">---- Non Cardiac surgery (3 studies did not specify the operative setting)</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">76</td>
<td align="left" rowspan="1" colspan="1">76</td>
<td align="left" rowspan="1" colspan="1">−0.15</td>
<td align="left" rowspan="1" colspan="1">−0.47 to 0.17</td>
<td align="left" rowspan="1" colspan="1">0.4</td>
<td align="left" rowspan="1" colspan="1">0.8</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-ICU patients (non elective postoperative)</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">850</td>
<td align="left" rowspan="1" colspan="1">732</td>
<td align="left" rowspan="1" colspan="1">−0.52</td>
<td align="left" rowspan="1" colspan="1">−1.25 to 0.21</td>
<td align="left" rowspan="1" colspan="1">0.16</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">97</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">-excluding outlier studies <xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref>, <xref ref-type="bibr" rid="pone.0082913-Reade1">[32]</xref>, <xref ref-type="bibr" rid="pone.0082913-Riker1">[33]</xref></td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">995</td>
<td align="left" rowspan="1" colspan="1">993</td>
<td align="left" rowspan="1" colspan="1">−0.16</td>
<td align="left" rowspan="1" colspan="1">−0.26 to −0.05</td>
<td align="left" rowspan="1" colspan="1">0.003</td>
<td align="left" rowspan="1" colspan="1">0.04</td>
<td align="left" rowspan="1" colspan="1">39</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Long term sedation</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">830</td>
<td align="left" rowspan="1" colspan="1">712</td>
<td align="left" rowspan="1" colspan="1">−0.65</td>
<td align="left" rowspan="1" colspan="1">−1.44 to 0.15</td>
<td align="left" rowspan="1" colspan="1">0.11</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">98</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Short term sedation</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">974</td>
<td align="left" rowspan="1" colspan="1">962</td>
<td align="left" rowspan="1" colspan="1">−0.28</td>
<td align="left" rowspan="1" colspan="1">−0.49 to −0.07</td>
<td align="left" rowspan="1" colspan="1">0.009</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">76</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Daily interruption sedation</td>
<td align="left" rowspan="1" colspan="1">4</td>
<td align="left" rowspan="1" colspan="1">785</td>
<td align="left" rowspan="1" colspan="1">664</td>
<td align="left" rowspan="1" colspan="1">−0.69</td>
<td align="left" rowspan="1" colspan="1">−1.70 to 0.32</td>
<td align="left" rowspan="1" colspan="1">0.18</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">99</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- High maintenance dose</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">859</td>
<td align="left" rowspan="1" colspan="1">737</td>
<td align="left" rowspan="1" colspan="1">−0.42</td>
<td align="left" rowspan="1" colspan="1">−1.13 to 0.30</td>
<td align="left" rowspan="1" colspan="1">0.3</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">76</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Low maintenance dose(&lt;0.7 µg kg−1 h−1)</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">843</td>
<td align="left" rowspan="1" colspan="1">839</td>
<td align="left" rowspan="1" colspan="1">−0.30</td>
<td align="left" rowspan="1" colspan="1">−0.53 to −0.07</td>
<td align="left" rowspan="1" colspan="1">0.009</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">76</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Loading dose</td>
<td align="left" rowspan="1" colspan="1">16</td>
<td align="left" rowspan="1" colspan="1">734</td>
<td align="left" rowspan="1" colspan="1">731</td>
<td align="left" rowspan="1" colspan="1">−0.23</td>
<td align="left" rowspan="1" colspan="1">−0.47 to 0.001</td>
<td align="left" rowspan="1" colspan="1">0.051</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">75</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- No loading dose</td>
<td align="left" rowspan="1" colspan="1">7</td>
<td align="left" rowspan="1" colspan="1">968</td>
<td align="left" rowspan="1" colspan="1">845</td>
<td align="left" rowspan="1" colspan="1">−0.60</td>
<td align="left" rowspan="1" colspan="1">−1.25 to 0.05</td>
<td align="left" rowspan="1" colspan="1">0.07</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">97</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">- Loading dose and high maintenance dose</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">74</td>
<td align="left" rowspan="1" colspan="1">73</td>
<td align="left" rowspan="1" colspan="1">−0.08</td>
<td align="left" rowspan="1" colspan="1">−0.44 to 0.27</td>
<td align="left" rowspan="1" colspan="1">0.3</td>
<td align="left" rowspan="1" colspan="1">0.3</td>
<td align="left" rowspan="1" colspan="1">11</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SENSITIVITY (including only blinded studies)</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">1241</td>
<td align="left" rowspan="1" colspan="1">1112</td>
<td align="left" rowspan="1" colspan="1">−0.56</td>
<td align="left" rowspan="1" colspan="1">−1.06 to −0.05</td>
<td align="left" rowspan="1" colspan="1">0.03</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">97</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SENSITIVITY (including only low risk of bias studies)</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">1023</td>
<td align="left" rowspan="1" colspan="1">899</td>
<td align="left" rowspan="1" colspan="1">−0.72</td>
<td align="left" rowspan="1" colspan="1">−1.34 to −0.10</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">97</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SENSITIVITY (removing 1 study at time)</td>
<td colspan="8" align="left" rowspan="1">All 95% CIs of SDM&lt;0 and p&lt;0.05</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SENSITIVITY(Jakob study <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref> included as time on mechanical ventilation) <xref ref-type="table-fn" rid="nt105">*</xref></td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">1,804</td>
<td align="left" rowspan="1" colspan="1">1,674</td>
<td align="left" rowspan="1" colspan="1">−0.38</td>
<td align="left" rowspan="1" colspan="1">−0.66 to −0.10</td>
<td align="left" rowspan="1" colspan="1">0.007</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">93</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SMALL STUDY EFFECT (fixed model)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">−0.31</td>
<td align="left" rowspan="1" colspan="1">−0.38 to 0.24</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p>The overall analyses using weighted mean differences showed a reduction in intensive care unit stay of −0.79 [−1.17 to −0.40] days and a reduction in time to extubation of −2.74 [−3.80 to −1.65] hours in the dexmedetomidine group. It should be noted that the standard mean differences used in this table is not expressed in days or hours.</p></fn><fn id="nt104"><label/><p>Dex: dexmedetomidine; SMD: standardized mean difference; CI: confidence interval; P: p-value; CABG: coronary artery bypass grafting; ICU: intensive care unit; NIV: non invasive ventilation.</p></fn><fn id="nt105"><label/><p>duration of mechanical ventilation from randomization until patients were free of mechanical ventilation(including noninvasive).</p></fn></table-wrap-foot></table-wrap>
<p>The use of dexmedetomidine was also associated (<xref ref-type="fig" rid="pone-0082913-g003">figure 3</xref>; <xref ref-type="supplementary-material" rid="pone.0082913.s003">figure S2</xref>) with a significant reduction of time to extubation (WMD = −2.74 [−3.80 to −1.65] hours, p for effect &lt;0.001, p for heterogeneity&lt;0.001,I<sup>2</sup> = 96%, SMD = −0.39 [−0.66 to −0.11], p for effect = 0.005, p for heterogeneity &lt;0.001, I<sup>2</sup> = 93% with 24 studies and 3,478 patients included). Further subanalyses, detailed in <xref ref-type="table" rid="pone-0082913-t003">table 3</xref>, confirmed these findings in patients receiving short term sedation (SMD = −0.28 [−0.49 to −0.07], p for effect = 0.009 with 18 studies included), in those receiving a low (&lt;0.7 µg kg−1 h−1) maintenance dose (SMD = −0.30 [−0.53 to −0.07], p for effect = 0.009 with 16 studies included) and in those undergoing elective surgery (SMD = −0.31 [−0.52 to −0.09], p for effect = 0.005 with 17 studies included) with most of the positive finding coming from the cardiac surgery setting (SMD = −0.42 [−0.75 to −0.10], p for effect = 0.01 with 10 studies included). The largest study <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref> included in this meta-analysis was also the only one to report both median and mean values for mechanical ventilation. Since these data were skewed, we repeated the analyses including median instead of mean values and didn't find differences in pooled estimate results (SMD = −0.39, 95% CI −0.66 to −0.12, I-square = 93%).</p>
<fig id="pone-0082913-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.g003</object-id><label>Figure 3</label><caption>
<title>Forest plot for the time to extubation.</title>
<p>Overall analysis showed that the use of dexmedetomidine was associated with a significant reduction of time to extubation (SMD = −0.39 [−0.66 to −0.11], p for effect = 0.005, p for heterogeneity &lt;0.001, I2 = 93% with 24 studies and 3,478 patients included). CI = confidence interval; SMD = standardized mean difference; N = number; SD = standard deviation; Dex = dexmedetomidine.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.g003" position="float" xlink:type="simple"/></fig>
<p>Further subanalyses with the different comparators (propofol, midazolam, placebo and morphine) are detailed in supplemental material (<xref ref-type="supplementary-material" rid="pone.0082913.s007">TableS2</xref> <xref ref-type="supplementary-material" rid="pone.0082913.s008">Table S3</xref>, <xref ref-type="supplementary-material" rid="pone.0082913.s009">Table S4</xref> and <xref ref-type="supplementary-material" rid="pone.0082913.s010">Table S5</xref>) but were not informative with respect to ICU stay or time to extubation due to the paucity of trials included.</p>
<p>Visual inspection of funnel and scatter plots (<xref ref-type="fig" rid="pone-0082913-g004">figures 4</xref> and <xref ref-type="fig" rid="pone-0082913-g005">5</xref>; <xref ref-type="supplementary-material" rid="pone.0082913.s004">figures S3</xref> and <xref ref-type="supplementary-material" rid="pone.0082913.s005">S4</xref>) did not identify a skewed or asymmetrical shape for the co-primary endpoints. Quantitative evaluation did not suggest a presence of publication bias, as measured by the Egger's test (p = 0.4 for the length of ICU stay and p = 0.5 for time to extubation) and Peters' test (p = 0.6 for the length of ICU stay and p = 0.9 for time to extubation). Since the funnel plots identified three outlier studies <xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref>, <xref ref-type="bibr" rid="pone.0082913-Reade1">[32]</xref>, <xref ref-type="bibr" rid="pone.0082913-Riker1">[33]</xref> we repeated the analyses removing them and found that the statistically significant difference in ICU stay and time to extubation was maintained (p = 0.005 and p = 0.003 respectively ) and the heterogeneity reduced (I<sup>2</sup> = 28% and I<sup>2</sup> = 39% respectively ) (<xref ref-type="table" rid="pone-0082913-t003">table 3</xref>).</p>
<fig id="pone-0082913-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.g004</object-id><label>Figure 4</label><caption>
<title>Funnel plot for the length of ICU stay.</title>
<p>Visual inspection of funnel plots did not identify a skewed or asymmetrical shape for the co-primary endpoints. Quantitative evaluation did not suggest a presence of publication bias, as measured by the Egger's test (p = 0.4) and Peters' test (p = 0.6). ICU = intensive care unit; SE = standard error; SMD = standardized mean difference.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.g004" position="float" xlink:type="simple"/></fig><fig id="pone-0082913-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.g005</object-id><label>Figure 5</label><caption>
<title>Funnel plot for the time to extubation.</title>
<p>Visual inspection of funnel plots did not identify a skewed or asymmetrical shape for the co-primary endpoints. Quantitative evaluation did not suggest a presence of publication bias, as measured by the Egger's test (p = 0.5) and Peters' test (p = 0.9). SE = standard error; SMD =  standardized mean difference.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.g005" position="float" xlink:type="simple"/></fig></sec><sec id="s3b2">
<title>Effect of dexmedetomidine on rescue doses of analgesic drugs, incidence of bradycardia, hypotension and mortality</title>
<p>Rescue doses of sedative or analgesic drugs were required less in the dexmedetomidine patients (892/1,459 [61%] in the dexmedetomidine group versus 977/1,366 [72%] in the control arm, p = 0.01 with 14 studies included). A subanalysis showed that dexmedetomidine was associated with a significant reduction in the number of patients requiring rescue doses of analgesic drugs (691/927 [67%] in the dexmedetomidine group versus 624/802 [78%] in the control arm, RR = 0.80 [0.66 to 0.98], p = 0.03) with no differences in the number of patients requiring rescue doses of sedative drugs (271/532 [51%] in the dexmedetomidine group versus 353/564 [63%] in the control arm, p = 0.3) (<xref ref-type="table" rid="pone-0082913-t004">Table 4</xref>).</p>
<table-wrap id="pone-0082913-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0082913.t004</object-id><label>Table 4</label><caption>
<title>Secondary Outcomes.</title>
</caption><alternatives><graphic id="pone-0082913-t004-4" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0082913.t004" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Outcome</td>
<td align="left" rowspan="1" colspan="1">Number of included trials</td>
<td align="left" rowspan="1" colspan="1">Dex patients</td>
<td align="left" rowspan="1" colspan="1">Control patients</td>
<td align="left" rowspan="1" colspan="1">RR</td>
<td align="left" rowspan="1" colspan="1">95% CI</td>
<td align="left" rowspan="1" colspan="1">P for effect</td>
<td align="left" rowspan="1" colspan="1">P for heterogeneity</td>
<td align="left" rowspan="1" colspan="1">I<sup>2</sup> (%)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Overall trials</td>
<td align="left" rowspan="1" colspan="1">28 trials (27 manuscripts)</td>
<td align="left" rowspan="1" colspan="1">1,870</td>
<td align="left" rowspan="1" colspan="1">1,778</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Mortality</bold></td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">200/1,499 [13%]</td>
<td align="left" rowspan="1" colspan="1">173/1,409 [12%]</td>
<td align="left" rowspan="1" colspan="1">1.00</td>
<td align="left" rowspan="1" colspan="1">0.84 to 1.21</td>
<td align="left" rowspan="1" colspan="1">0.9</td>
<td align="left" rowspan="1" colspan="1">0.9</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Hypotension</bold></td>
<td align="left" rowspan="1" colspan="1">19</td>
<td align="left" rowspan="1" colspan="1">424/1,389 [31%]</td>
<td align="left" rowspan="1" colspan="1">279/1,266 [22%]</td>
<td align="left" rowspan="1" colspan="1">1.27</td>
<td align="left" rowspan="1" colspan="1">1.00 to 1.61</td>
<td align="left" rowspan="1" colspan="1">0.052</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">62</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Bradycardia</bold></td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">220/1,374 [16%]</td>
<td align="left" rowspan="1" colspan="1">64/1,246 [5%]</td>
<td align="left" rowspan="1" colspan="1">2.43</td>
<td align="left" rowspan="1" colspan="1">1.88 to 3.14</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">0.9</td>
<td align="left" rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Patients requiring rescue doses of either sedatives or analgesics</bold></td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">892/1,459 [61%]</td>
<td align="left" rowspan="1" colspan="1">977/1,366 [72%]</td>
<td align="left" rowspan="1" colspan="1">0.81</td>
<td align="left" rowspan="1" colspan="1">0.70 to 0.95</td>
<td align="left" rowspan="1" colspan="1">0.01</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">84</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">---requiring sedative drugs</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">271/532 [51%]</td>
<td align="left" rowspan="1" colspan="1">353/564 [63%]</td>
<td align="left" rowspan="1" colspan="1">0.84</td>
<td align="left" rowspan="1" colspan="1">0.62 to 1.14</td>
<td align="left" rowspan="1" colspan="1">0.3</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">82</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">---requiring analgesic drugs</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">621/927 [67%]</td>
<td align="left" rowspan="1" colspan="1">624/802 [78%]</td>
<td align="left" rowspan="1" colspan="1">0.80</td>
<td align="left" rowspan="1" colspan="1">0.66 to 0.98</td>
<td align="left" rowspan="1" colspan="1">0.03</td>
<td align="left" rowspan="1" colspan="1">&lt;0.001</td>
<td align="left" rowspan="1" colspan="1">88</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Number of patients completely comfortable</bold></td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">112/253 [44%]</td>
<td align="left" rowspan="1" colspan="1">103/254 [40.6%]</td>
<td align="left" rowspan="1" colspan="1">1.07</td>
<td align="left" rowspan="1" colspan="1">0.49 to 2.49</td>
<td align="left" rowspan="1" colspan="1">0.9</td>
<td align="left" rowspan="1" colspan="1">0.003</td>
<td align="left" rowspan="1" colspan="1">82</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt106"><label/><p>Dex: dexmedetomidine; RR: relative risk; CI: confidence interval; P: p-value.</p></fn></table-wrap-foot></table-wrap>
<p>Dexmedetomidine was associated with an increased rate of bradycardia (220/1,374 [16%] in the dexmedetomidine group vs 64/1,246 [5%] in the control group, RR = 2.43[1.88 to 3.14], p for effect &lt;0.001, p for heterogeneity = 0.9, I<sup>2</sup> = 0% with 17 studies included) and with a trend towards an increased rate of hypotension (424/1,389 [31%] in the dexmedetomidine group vs 279/1,266 [22%] in the control group, RR = 1.27[1.00 to 1.61], p for effect 0.052, p for heterogeneity &lt;0.001, I<sup>2</sup> = 62% with 19 studies included) (<xref ref-type="table" rid="pone-0082913-t004">Table 4</xref>).</p>
<p>No difference in mortality was recorded at the longest follow-up available (200/1,499 [13%] in the dexmedetomidine group vs 173/1,409 [12%] in the control group, RR = 1.00 [0.84 to 1.21], p for effect = 0.9 with 20 studies included). The univariate meta-regression of average follow-up against log-risk mortality showed no significant effects for time on mortality (n = 20, slope coefficient = −0.001 [−0.003 to 0.001], p = 0.31) (<xref ref-type="table" rid="pone-0082913-t004">Table 4</xref>).</p>
</sec></sec><sec id="s3c">
<title>Sensitivity analyses</title>
<p>Estimate results from both random and fixed effect models were extremely similar (<xref ref-type="table" rid="pone-0082913-t003">table 3</xref>); hence we excluded a considerable small study effect. Sensitivity analyses performed by sequentially removing each study and reanalysing the remaining dataset (producing a new analysis for each study removed), did not determine major changes in direction or magnitude of statistical findings, confirming the pooled effect of each co-primary endpoints (all SWD&lt;1) and the statistical significance (all p of effect &lt;0 .05). Sensitivity analyses carried out with studies with low risk of bias confirmed the overall results of our work showing a reduction in length of ICU stay in dexmedetomidine versus control group (SMD = −0.44 [−0.86 to −0.02] p for effect = 0.04, p for heterogeneity &lt;0.001, I<sup>2</sup> = 94% with 10 studies and 2,005 patients included) and in time to extubation (SMD = −0.72 [−1.34 to −0.10], p for effect = 0.02, p for heterogeneity &lt;0.001, I<sup>2</sup> = 97% with 8 studies and 1,922 patients included). Sensitivity analyses carried out with blinded studies confirmed the overall results of our work showing a reduction in length of ICU stay in dexmedetomidine versus control group (SMD = −0.56 [−1.09 to −0.04], p for effect = 0.04, p for heterogeneity &lt;0.001, I<sup>2</sup> = 95% with 8 studies and 1,659patients included) and a reduction in time to extubation (SMD = −0.56 [−1.06 to 0.05], p for effect = 0.03, p for heterogeneity &lt;0.001, I<sup>2</sup> = 97% with 10 studies and 2,353 patients included).</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>Our meta-analysis confirmed that dexmedetomidine is associated with a reduction in ICU stay and suggested that it might reduce the time of extubation when compared to other sedative or hypnotic agent. Even if dexmedetomidine is associated with an increase in the risk of bradycardia and with a trend toward an increased risk of hypotension, no detrimental effects on mortality were detected.</p>
<p>The ideal sedative agent should provide anticipated, predictable effects, rapid onset, and quick recovery. It should be easy to administer with no adverse events, no interaction with other drugs, no accumulation of metabolites and no withdrawal effects at the end of infusion. Unluckily an ideal sedative agent that can suit the need of all patients does not yet exist.</p>
<p>Dexmedetomidine is one of the most recently released intravenous agents for sedation in the ICU, though the drug started to be investigated more than 20 years ago. It was introduced in clinical practice in the United States in 1999 while the European Medicine Agency authorised its use for all 27 European member states in September 2011. It is an alpha2-agonist and produces sedation acknowledged as “cooperative” or “arousable”, which is different from the sedation “clouding of consciousness” induced by drugs acting on GABA receptors, such as midazolam or propofol <xref ref-type="bibr" rid="pone.0082913-Aho1">[39]</xref>. Tan and Ho, in a previous meta-analysis updated on December 2009 <xref ref-type="bibr" rid="pone.0082913-Tan1">[6]</xref> reported that when dexmedetomidine was compared with alternative sedative agents it was associated with a statistically significant reduction in length of ICU stay, but not in duration of mechanical ventilation. We updated their findings on February 2013 identifying eight recently published manuscripts <xref ref-type="bibr" rid="pone.0082913-AbdAziz1">[7]</xref>–<xref ref-type="bibr" rid="pone.0082913-Khalil1">[14]</xref> and one trial that was not identified in their systematic search <xref ref-type="bibr" rid="pone.0082913-Sahin1">[15]</xref>, thus increasing the number of patients by 50% (up to 3,648 overall randomized patients included in our meta-analysis) and providing more robust safety data. By adding more patients data we were able to show, for the first time in a meta-analysis, that dexmedetomidine increases the rate of bradycardia when all trials are pooled together and also shows a trend towards an increase rate of hypotension. However, these side effects were not associated with differences in mortality (200/1499 [13%] in the dexmedetomidine group vs 173/1409 [12%] in the control group, p = 0.9 with 20 studies included).</p>
<p>Dexmedetomidine decreases sympathetic nervous system activity and is therefore associated with an increase in cardiovascular adverse events. These effects may be most pronounced in patients with decreased autonomic nervous system response such as the elderly, diabetic patients, patients with chronic hypertension or severe cardiac disease such as valve stenosis or regurgitation, advanced heart block, severe coronary artery disease, or in patients who are already hypotensive and/or hypovolemic <xref ref-type="bibr" rid="pone.0082913-Gertler1">[40]</xref>. Therefore, in patients who depend on a high level of sympathetic tone or in patients with reduced myocardial function who cannot tolerate the decrease in sympathetic tone, loading doses of dexmedetomidine should be avoided. On the other side, the characteristics of dexmedetomidine to provide an ongoing sedation and sympathetic block could be beneficial in reducing early postoperative ischemic events in high-risk patients <xref ref-type="bibr" rid="pone.0082913-Talke1">[41]</xref>–<xref ref-type="bibr" rid="pone.0082913-Chorney1">[42]</xref>.</p>
<p>Intravenous administration of dexmedetomidine exhibits the following pharmacokinetic parameters: a rapid distribution phase with an half-life (t 1/2 α) of 6 min, a terminal elimination half-life (t 1/2 β) of 2 hours, and a steady-state volume of distribution (Vss) of 118 litres. It presents linear kinetics when infused in the range of 0.2–0.7 µg/kg/h for no more than 24 hours and undergoes almost complete biotransformation through direct glucuronidation and cytochrome P450 metabolism. Consequently it can accumulate in patients who are on P450 enzyme inhibitors, some of which are commonly used in ICU. Metabolites of biotransformation are excreted in the urine (95%) and faeces <xref ref-type="bibr" rid="pone.0082913-YazbekKaram1">[43]</xref>.</p>
<sec id="s4a">
<title>Limitations</title>
<p>We acknowledge that this study has several limitations. The quality of the included studies is not high since only 13 of them were blind. Moreover we noted high heterogeneity between the included studies. The heterogeneity remained when sensitivity analyses on studies with low risk of bias where performed. It was abolished only removing three outliers studies cited above. Nonetheless we excluded the possible influence of small-study effects on the results of our meta-analysis comparing the fixed- and random-effects estimates of the treatment effect (<xref ref-type="table" rid="pone-0082913-t003">table 3</xref>). The overall reduction in ICU stay and time to extubation may appear clinically modest, but it should be acknowledged that the largest study <xref ref-type="bibr" rid="pone.0082913-Jakob1">[8]</xref> had very conservative imputation rules (to worst outcome) and this might have softened our results.</p>
</sec></sec><sec id="s5">
<title>Conclusions</title>
<p>Dexmedetomidine for sedation in mechanically ventilated critically ill adult patients seems to help to reduce time to extubation and ICU stay. The known side effects (increased incidence of bradycardia and a trend toward an increased risk of hypotension) had no effect on the overall mortality in this meta-analysis of all the RCTs published so far.</p>
<p>Larger, multicentre, randomized clinical trials, especially in long term sedated patients requiring mechanical ventilation, would be welcome to confirm these findings.</p>
</sec><sec id="s6">
<title>Supporting Information</title>
<supplementary-material id="pone.0082913.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0082913.s001" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA checklist.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s002" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0082913.s002" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Forest plot for the length of ICU stay using standard mean difference (days) instead of weighted mean difference (absolute value with no units of measurement).</bold> Overall analysis showed that the use of dexmedetomidine was associated with a significant reduction in length of ICU stay (SMD = −0.48 [−0.78 to −0.18], p for effect = 0.002, p for heterogeneity &lt;0.001, I2 = 91% with 17 studies and 2,424 patients included). ICU = intensive care unit; CI = confidence interval; SMD = standardized mean difference; N = number; SD = standard deviation.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s003" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0082913.s003" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold>Forest plot for the time to extubation using standard mean difference (days) instead of weighted mean difference (absolute value with no units of measurement)..</bold> Overall analysis showed that the use of dexmedetomidine was associated with a significant reduction of time to extubation (SMD = −0.39 [−0.66 to −0.11], p for effect = 0.005, p for heterogeneity &lt;0.001, I2 = 93% with 24 studies and 3,478 patients included). CI = confidence interval; SMD =  standardized mean difference; N = number; SD = standard deviation</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s004" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0082913.s004" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold>Scatter plot for ICU stay</bold></p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s005" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0082913.s005" position="float" xlink:type="simple"><label>Figure S4</label><caption>
<p><bold>Scatter plot for time to extubation</bold></p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s006" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0082913.s006" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p><bold>Methodological quality summary: review authors' judgments about each methodological quality item for each included study.</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s007" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0082913.s007" position="float" xlink:type="simple"><label>Table S2</label><caption>
<p><bold>Subanalysis with propofol as comparator drug</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s008" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0082913.s008" position="float" xlink:type="simple"><label>Table S3</label><caption>
<p><bold>Subanalysis with midazolam as comparator drug</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s009" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0082913.s009" position="float" xlink:type="simple"><label>Table S4</label><caption>
<p><bold>Subanalysis with morphine as comparator drug</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s010" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0082913.s010" position="float" xlink:type="simple"><label>Table S5</label><caption>
<p><bold>Subanalysis with placebo as comparator drug</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s011" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0082913.s011" position="float" xlink:type="simple"><label>Text S1</label><caption>
<p><bold>Full PubMed search strategy</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s012" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0082913.s012" position="float" xlink:type="simple"><label>Text S2</label><caption>
<p><bold>Major exclusions</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material><supplementary-material id="pone.0082913.s013" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.pone.0082913.s013" position="float" xlink:type="simple"><label>Text S3</label><caption>
<p><bold>References of the excluded studies</bold></p>
<p>(DOCX)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0082913-Paris1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paris</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tonner</surname><given-names>PH</given-names></name> (<year>2005</year>) <article-title>Dexmedetomidine in anaesthesia</article-title>. <source>CurrOpinAnaesthesiol</source> <volume>18</volume>: <fpage>412</fpage>–<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Huupponen1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huupponen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Maksimow</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lapinlampi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Särkelä</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Saastamoinen</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep</article-title>. <source>Acta Anaesthesiol Scand</source> <volume>52</volume>: <fpage>289</fpage>–<lpage>94</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Guo1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname><given-names>TZ</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Buttermann</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Maze</surname><given-names>M</given-names></name> (<year>1996</year>) <article-title>Dexmedetomidine injection into the locus ceruleus produces antinociception</article-title>. <source>Anesthesiology</source> <volume>84</volume>: <fpage>873</fpage>–<lpage>81</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Iirola1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iirola</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Aantaa</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laitio</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kentala</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lahtinen</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients</article-title>. <source>Crit Care</source> <volume>15</volume>: <fpage>R257</fpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Morsch1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Morsch</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Ferri</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Vasconcelos</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Capone Neto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Akamine</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Dexmedetomidine as a sedative agent for more than 24 hours in acutely ill patients</article-title>. <source>Critical Care</source> <volume>9</volume>: <fpage>P111</fpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Tan1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tan</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>KM</given-names></name> (<year>2010</year>) <article-title>Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis</article-title>. <source>Intensive Care Med</source> <volume>36</volume>: <fpage>926</fpage>–<lpage>39</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-AbdAziz1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abd Aziz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Chue</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Yong</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Hassan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Awaisu</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Efficacy and safety of dexmedetomidine versus morphine in post-operative cardiac surgery patients</article-title>. <source>Int J Clin Pharm</source> <volume>33</volume>: <fpage>150</fpage>–<lpage>4</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Jakob1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jakob</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Ruokonen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Grounds</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Sarapohja</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Garratt</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Dexmedetomidinevs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials</article-title>. <source>JAMA</source> <volume>307</volume>: <fpage>1151</fpage>–<lpage>60</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Leino1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leino</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hynynen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jalonen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Salmenperä</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Scheinin</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study</article-title>. <source>BMC Anesthesiol</source> <volume>11</volume>: <fpage>9</fpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Menda1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Menda</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Köner</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Sayin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Türe</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Imer</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Dexmedetomidine as an adjunct to anesthetic induction to attenuate hemodynamic response to endotracheal intubation in patients undergoing fast-track CABG</article-title>. <source>Ann Card Anaesth</source> <volume>13</volume>: <fpage>16</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Terao1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Terao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ichinomiya</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Higashijima</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Tanise</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Miura</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Comparison between propofol and dexmedetomidine in postoperative sedation after extensive cervical spine surgery</article-title>. <source>J Anesth</source> <volume>26</volume>: <fpage>179</fpage>–<lpage>86</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Wan1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wan</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>QQ</given-names></name>, <name name-style="western"><surname>Yue</surname><given-names>JX</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>SH</given-names></name> (<year>2011</year>) <article-title>Comparison of sedative effect of dexmedetomidine and midazolam for post-operative patients undergoing mechanical ventilation in surgical intensive care unit</article-title>. <source>Zhongguo Wei Zhong Bing Ji Jiu Yi Xue</source> <volume>23</volume>: <fpage>543</fpage>–<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Yao1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yao</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>JJ</given-names></name> (<year>2010</year>) <article-title>The role of dexmedetomidine in treatment of serious patients in intensive care unit</article-title>. <source>Zhongguo Wei Zhong Bing Ji Jiu Yi Xue</source> <volume>22</volume>: <fpage>632</fpage>–<lpage>4</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Khalil1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khalil</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Abdel Azeem</surname><given-names>MS</given-names></name> (<year>2013</year>) <article-title>The impact of dexmedetomidine infusion in sparing morphine consumption in off-pump coronary artery bypass grafting</article-title>. <source>Semin CardiothoracVasc Anesth</source> <volume>17</volume>: <fpage>66</fpage>–<lpage>71</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Sahin1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sahin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kabukcu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ozkan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Titiz</surname><given-names>T</given-names></name> (<year>2005</year>) <article-title>The effects of postoperative dexmedetomidine and midazolam infusion on haemodynamics and sedation in patients after coronary artery bypass grafting</article-title>. <source>Eur J Anaesthesiol</source> <volume>22</volume>: <fpage>40</fpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Higgins1"><label>16</label>
<mixed-citation publication-type="other" xlink:type="simple">Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Available: <ext-link ext-link-type="uri" xlink:href="http://handbook.cochrane.org/" xlink:type="simple">http://handbook.cochrane.org/</ext-link> Accessed October 2013.</mixed-citation>
</ref>
<ref id="pone.0082913-Begg1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Peters1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peters</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Sutton</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Abrams</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Rushton</surname><given-names>L</given-names></name> (<year>2006</year>) <article-title>Comparison of two methods to detect publication bias in meta-analysis</article-title>. <source>JAMA</source> <volume>295</volume>: <fpage>676</fpage>–<lpage>80</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-BiondiZoccai1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Biondi-Zoccai</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lotrionte</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Landoni</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Modena</surname><given-names>MG</given-names></name> (<year>2011</year>) <article-title>The rough guide to systematic reviews and meta-analyses</article-title>. <source>HSR Proceedings in Intensive Care and Cardiovascular Anesthesia</source> <volume>3</volume>: <fpage>161</fpage>–<lpage>173</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Liberati1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liberati</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mulrow</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gøtzsche</surname><given-names>PC</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration</article-title>. <source>BMJ</source> <volume>339</volume>: <fpage>b2700</fpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Corbett1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Corbett</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Rebuck</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Greene</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Callas</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Neale</surname><given-names>BW</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation</article-title>. <source>Crit Care Med</source> <volume>33</volume>: <fpage>940</fpage>–<lpage>5</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Elbaradie1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Elbaradie</surname><given-names>S</given-names></name>, <name name-style="western"><surname>El Mahalawy</surname><given-names>FH</given-names></name>, <name name-style="western"><surname>Solyman</surname><given-names>AH</given-names></name> (<year>2004</year>) <article-title>Dexmedetomidine vs. propofol for short-term sedation of postoperative mechanically ventilated patients</article-title>. <source>J Egypt Natl CancInst</source> <volume>16</volume>: <fpage>153</fpage>–<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Esmaoglu1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Esmaoglu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ulgey</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Akin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boyaci</surname><given-names>A</given-names></name> (<year>2009</year>) <article-title>Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit</article-title>. <source>J Crit Care</source> <volume>24</volume>: <fpage>551</fpage>–<lpage>5</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Herr1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herr</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Sum-Ping</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>England</surname><given-names>M</given-names></name> (<year>2003</year>) <article-title>ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens</article-title>. <source>J Cardiothorac Vasc Anesth</source> <volume>17</volume>: <fpage>576</fpage>–<lpage>84</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Maldonado1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maldonado</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Wysong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>van der Starre</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Block</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery</article-title>. <source>Psychosomatics</source> <volume>50</volume>: <fpage>206</fpage>–<lpage>17</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Martin1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martin</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ramsay</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mantz</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sum-Ping</surname><given-names>ST</given-names></name> (<year>2003</year>) <article-title>The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit</article-title>. <source>J Intensive Care Med</source> <volume>18</volume>: <fpage>29</fpage>–<lpage>41</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Memis1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Memis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Dökmeci</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Karamanlioglu</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Turan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Türe</surname><given-names>M</given-names></name> (<year>2006</year>) <article-title>A comparison of the effect on gastric emptying of propofol or dexmedetomidine in critically ill patients: preliminary study</article-title>. <source>Eur J Anaesthesiol</source> <volume>23</volume>: <fpage>700</fpage>–<lpage>04</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Memi1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Memiş</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hekimoğlu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vatan</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Yandim</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yüksel</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients</article-title>. <source>Br J Anaesth</source> <volume>98</volume>: <fpage>550</fpage>–<lpage>2</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Memi2"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Memiş</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kargi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sut</surname><given-names>N</given-names></name> (<year>2009</year>) <article-title>Effects of propofol and dexmedetomidine on indocyanine green elimination assessed with LIMON to patients with early septic shock: a pilot study</article-title>. <source>J Crit Care</source> <volume>24</volume>: <fpage>603</fpage>–<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Ozkan1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ozkan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sahin</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Karakaya Kabukcu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Celikbilek</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Aydogdu Titiz</surname><given-names>T</given-names></name> (<year>2007</year>) <article-title>Comparison of the effects of dexmedetomidine with midasolam on haemodynamics and oxygen profile in patients undergoing coronary artery bypass grafting</article-title>. <source>Gogus-Kalp-Damar Anestezive Yogun Bakim Dernegi Dergisi</source> <volume>13</volume>: <fpage>161</fpage>–<lpage>168</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Pandharipande1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pandharipande</surname><given-names>PP</given-names></name>, <name name-style="western"><surname>Pun</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Herr</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Maze</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Girard</surname><given-names>TD</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Effect of sedation with dexmedetomidinevslorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial</article-title>. <source>JAMA</source> <volume>298</volume>: <fpage>2644</fpage>–<lpage>2653</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Reade1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reade</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>O'Sullivan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bates</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Goldsmith</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ainslie</surname><given-names>WR</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial</article-title>. <source>Crit Care</source> <volume>13</volume>: <fpage>R75</fpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Riker1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Riker</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Shehabi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bokesch</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Ceraso</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wisemandle</surname><given-names>W</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Dexmedetomidinevs midazolam for sedation of critically ill patients: a randomized trial</article-title>. <source>JAMA</source> <volume>301</volume>: <fpage>489</fpage>–<lpage>99</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Ruokonen1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ruokonen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Parviainen</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Jakob</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Nunes</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kaukonen</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation</article-title>. <source>J Intensive Care Med</source> <volume>35</volume>: <fpage>282</fpage>–<lpage>90</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Shehabi1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shehabi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wolfenden</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hammond</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bass</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidineCOmpared to Morphine-DEXCOM Study)</article-title>. <source>Anesthesiology</source> <volume>111</volume>: <fpage>1075</fpage>–<lpage>84</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Tasdogan1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tasdogan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Memis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sut</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yuksel</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis</article-title>. <source>J Clin Anesth</source> <volume>21</volume>: <fpage>394</fpage>–<lpage>400</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Triltsch1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Triltsch</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Welte</surname><given-names>M</given-names></name>, <name name-style="western"><surname>von Homeyer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Grosse</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Genähr</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study</article-title>. <source>Crit Care Med</source> <volume>30</volume>: <fpage>1007</fpage>–<lpage>14</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Venn1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Venn</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Grounds</surname><given-names>RM</given-names></name> (<year>2001</year>) <article-title>Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions</article-title>. <source>Br J Anaesth</source> <volume>87</volume>: <fpage>684</fpage>–<lpage>90</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Aho1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aho</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Erkola</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Kallio</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Scheinin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Korttila</surname><given-names>K</given-names></name> (<year>1993</year>) <article-title>Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole</article-title>. <source>J Clin Anesth</source> <volume>5</volume>: <fpage>194</fpage>–<lpage>203</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Gertler1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gertler</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Silvius</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>DH</given-names></name> (<year>2001</year>) <article-title>Dexmedetomidine: a novel secative-analgesic agent</article-title>. <source>Proc (Bayl Univ Med Cent)</source> <volume>14</volume>: <fpage>13</fpage>–<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Talke1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Talke</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Drasner</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. The Study of Perioperative Ischemia Research Group</article-title>. <source>Anesthesiology</source> <volume>82</volume>: <fpage>620</fpage>–<lpage>633</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-Chorney1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chorney</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Gooch</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Oberdier</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Keating</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Stahl</surname><given-names>RF</given-names></name> (<year>2013</year>) <article-title>The safety and efficacy of dexmedetomidinefor postoperative sedation in the cardiac surgery intensive care unit</article-title>. <source>HSR Proc Intensive Care Cardiovasc Anesth</source> <volume>5</volume> (<issue>1</issue>) <fpage>17</fpage>–<lpage>24</lpage>.</mixed-citation>
</ref>
<ref id="pone.0082913-YazbekKaram1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yazbek-Karam</surname><given-names>VG</given-names></name>, <name name-style="western"><surname>Aouad</surname><given-names>MM</given-names></name> (<year>2006</year>) <article-title>Perioperative uses of dexmedetomidine</article-title>. <source>Middle East J Anesthesiol</source> <volume>18</volume>: <fpage>1043</fpage>–<lpage>58</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>